Antiviral Favipiravir Successfully Treats Lassa Virus in Guinea Pigs

Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health (NIH) scientists and colleagues.

Read more View All News

This page was last updated on Friday, January 21, 2022